Journal of clinical gastroenterology
Cannabis Use in Metabolic Dysfunction-Associated Steatotic Liver Disease: Friend or Foe? A Retrospective Analysis.
Ruchir Paladiya, Anmol Singh, Madhav Changela, Mihir Shah, Carol Singh, Vikash Kumar, Aalam Sohal, Shreyans Doshi, Neil Parikh
Published: 202510.1097/MCG.0000000000002321
Abstract
BACKGROUND: Cannabis use (CU) has increased since its legalization, and we are currently assessing its impact on various chronic conditions. The literature supports the anti-inflammatory and antifibrotic effects of cannabidiol in various liver diseas…
Preview only. Read the full abstract at the source